Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab

Henoch-Schönlein purpura (HSP) is a systemic vasculitis involving small vessels with deposition of immunoglobulin A (IgA) complexes, usually affecting children. Compared with children, HSP in adults is more severe and frequently associated with cancer. We report the case of a 49-year-old woman with...

Full description

Saved in:
Bibliographic Details
Main Authors: Taylor Pindi Sala, Jean-Marie Michot, Renaud Snanoudj, Marion Dollat, Emmanuel Estève, Bernadette Marie, Yacine Taoufik, Jean-François Delfraissy, Thierry Lazure, Olivier Lambotte
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2014/619218
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555913175629824
author Taylor Pindi Sala
Jean-Marie Michot
Renaud Snanoudj
Marion Dollat
Emmanuel Estève
Bernadette Marie
Yacine Taoufik
Jean-François Delfraissy
Thierry Lazure
Olivier Lambotte
author_facet Taylor Pindi Sala
Jean-Marie Michot
Renaud Snanoudj
Marion Dollat
Emmanuel Estève
Bernadette Marie
Yacine Taoufik
Jean-François Delfraissy
Thierry Lazure
Olivier Lambotte
author_sort Taylor Pindi Sala
collection DOAJ
description Henoch-Schönlein purpura (HSP) is a systemic vasculitis involving small vessels with deposition of immunoglobulin A (IgA) complexes, usually affecting children. Compared with children, HSP in adults is more severe and frequently associated with cancer. We report the case of a 49-year-old woman with medical history of kidney transplantation for segmental glomerular hyalinosis. Eight years after the transplantation, while taking combined immunosuppressive therapy with tacrolimus and azathioprine indicated for the prevention against transplant rejection, she developed a Henoch-Schönlein purpura. Vasculitis involves skin and sciatic peroneal nerve and she received systemic corticosteroid treatment. Because of four relapses and corticosteroid dependence, the patient was treated with rituximab (two intravenous infusions of 1000 mg given two weeks apart). Successful outcome was observed along two years of follow-up. This new case of successful use of rituximab in HSP promotes more investigations of this treatment in clinical trials.
format Article
id doaj-art-3667b45c8cf1470281c499e0f2112a83
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-3667b45c8cf1470281c499e0f2112a832025-02-03T05:46:46ZengWileyCase Reports in Medicine1687-96271687-96352014-01-01201410.1155/2014/619218619218Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with RituximabTaylor Pindi Sala0Jean-Marie Michot1Renaud Snanoudj2Marion Dollat3Emmanuel Estève4Bernadette Marie5Yacine Taoufik6Jean-François Delfraissy7Thierry Lazure8Olivier Lambotte9Internal Medicine Department, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, FranceInternal Medicine Department, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, FranceDepartment of Nephrology and Adult Renal Transplantation, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades Hospital, 75015 Paris, FranceInternal Medicine Department, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, FranceInternal Medicine Department, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, FranceFaculty of Medicine Paris-Sud, 94276 Le Kremlin-Bicêtre Cedex, FranceFaculty of Medicine Paris-Sud, 94276 Le Kremlin-Bicêtre Cedex, FranceInternal Medicine Department, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, FranceDepartment of Pathology, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, FranceInternal Medicine Department, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, FranceHenoch-Schönlein purpura (HSP) is a systemic vasculitis involving small vessels with deposition of immunoglobulin A (IgA) complexes, usually affecting children. Compared with children, HSP in adults is more severe and frequently associated with cancer. We report the case of a 49-year-old woman with medical history of kidney transplantation for segmental glomerular hyalinosis. Eight years after the transplantation, while taking combined immunosuppressive therapy with tacrolimus and azathioprine indicated for the prevention against transplant rejection, she developed a Henoch-Schönlein purpura. Vasculitis involves skin and sciatic peroneal nerve and she received systemic corticosteroid treatment. Because of four relapses and corticosteroid dependence, the patient was treated with rituximab (two intravenous infusions of 1000 mg given two weeks apart). Successful outcome was observed along two years of follow-up. This new case of successful use of rituximab in HSP promotes more investigations of this treatment in clinical trials.http://dx.doi.org/10.1155/2014/619218
spellingShingle Taylor Pindi Sala
Jean-Marie Michot
Renaud Snanoudj
Marion Dollat
Emmanuel Estève
Bernadette Marie
Yacine Taoufik
Jean-François Delfraissy
Thierry Lazure
Olivier Lambotte
Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab
Case Reports in Medicine
title Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab
title_full Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab
title_fullStr Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab
title_full_unstemmed Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab
title_short Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab
title_sort successful outcome of a corticodependent henoch schonlein purpura adult with rituximab
url http://dx.doi.org/10.1155/2014/619218
work_keys_str_mv AT taylorpindisala successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT jeanmariemichot successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT renaudsnanoudj successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT mariondollat successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT emmanuelesteve successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT bernadettemarie successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT yacinetaoufik successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT jeanfrancoisdelfraissy successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT thierrylazure successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab
AT olivierlambotte successfuloutcomeofacorticodependenthenochschonleinpurpuraadultwithrituximab